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PURPOSE. Neovascular remodeling (NVR), the progression of small capillaries into large-caliber
arterioles with perivascular fibrosis, represents a major therapeutic challenge in neovascular
age-related macular degeneration (AMD). Neovascular remodeling occurs after laser-induced
choroidal neovascularization (CNV) in aged but not young mice. Additionally, bone marrow–
derived cells, including macrophages, endothelial precursor cells, and mesenchymal
precursor cells, contribute to CNV severity. In this study, we investigated the impact of
aged bone marrow transplantation (BMT) on the degree of fibrosis, size, and vascular
morphology of CNV lesions in a mouse model of laser-induced CNV.
METHODS. Young (2 months) and old (16 months) mice were transplanted with green
fluorescent protein (GFP)-labeled bone marrow isolated from either young or old donors.
Laser CNV was induced 1 month following transplant, and eyes were analyzed via choroidal
flat mounts and immunohistochemistry 1 month postlaser. The identity of cells infiltrating
CNV lesions was determined using specific markers for the labeled transplanted cells (GFPþ),
macrophages (F4/80þ), perivascular mesenchymal-derived cells (smooth muscle actin,
SMAþ), and endothelial cells (CD31þ).
RESULTS. Bone marrow transplantation from aged mice transferred susceptibility to NVR into
young recipients. Inversely, transplantation of young marrow into old mice prevented NVR,
preserving small size and minimal fibrosis. Mice with NVR demonstrated a greater relative
contribution of marrow-derived SMAþ perivascular mesenchymal cells as compared to other
cells.
CONCLUSIONS. Our findings indicate that the status of bone marrow is an important determining
factor of neovascular severity. Furthermore, we find that perivascular mesenchymal cells,
rather than endothelial cells, derived from aged bone marrow may contribute to increased
CNV severity in this murine model of experimental neovascularization.
Keywords: age-related macular degeneration, experimental choroidal neovascularization,
bone marrow–derived perivascular precursor cells, bone marrow transplantation,
neovascular remodeling
Persistent disease activity in spite of anti-vascular endothelialgrowth factor (VEGF) therapy remains a major unmet
therapeutic need in the treatment of neovascular age-related
macular degeneration (AMD), affecting up to 50% of treated
eyes.1 Persistent disease activity includes not only residual intra-
or subretinal fluid, but also enlargement of choroidal neovas-
cularization (CNV), formation of large-caliber branching arteri-
oles, and perivascular fibrosis. These features resemble the
experimental process of neovascular remodeling (NVR), the
progression of small capillaries into large-caliber arterioles with
perivascular fibrosis.2 Neovascular remodeling can be induced
in the laser CNV model under various conditions, including
after exposure of mice to cigarette smoke or systemic
inflammatory toxins (Ref. 3 and Espinosa-Heidmann DG, et al.
IOVS 2007;48:ARVO E-Abstract 6017). However, NVR occurs
after laser-induced CNV in aged mice without additional
manipulation. In contrast, unmanipulated young mice develop
small lesions with mostly capillaries and minimal fibrosis.4
Pathological new vessels are composed of vascular cells
derived from two sources: vascular cells derived from adjacent
normal vasculature and circulating vascular precursor cells
derived from the bone marrow (BM).5–10 In previous studies
using bone marrow transplantation (BMT), we have shown that
BM-derived endothelial and perivascular mesenchymal cells are
present within the experimental CNV lesion and contribute to
up to 40% of its cellular composition.11 Similar results have
been demonstrated in animal models of vascular injury,
including retinal neovascularization, tumor neovasculature,
and hind limb ischemia.12–14 Bone marrow–derived precursor
cells may be a source of cells that promote vascular repair in
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ischemic tissue.15–18 On the other hand, these cells may
contribute to vascular injury. Cornacchia et al.19 demonstrated
that BMT from diabetic mice transfers renal glomerulosclerosis
to nondiabetic recipients, and that diabetes-altered mesangial
precursor cells from the BM were the causative cell type.19
In this study, we examined the role of BM-derived vascular
precursor cells in the age-related regulation of NVR in
experimental laser-induced CNV. We hypothesized that pre-
cursor cells derived from aged BM and transplanted into young
recipients would transfer the severe NVR lesion phenotype
observed in older animals. Our results showed that BM from
aged mice indeed transferred susceptibility to NVR to young
mice, and that the more severe lesions appeared to contain a
greater proportion of circulating perivascular mesenchymal
precursor cell derivatives, including both vascular smooth




All animal experiments adhered to the ARVO Statement for
the Use of Animals in Ophthalmic and Vision Research
following institutionally approved protocols. Young (Y: 2–4
months) and old (O: 16–18 months) female wild-type C57BL/
6J mice were purchased from the National Institute of Aging
(NIA, Bethesda, MD) and served as ‘‘recipient’’ mice for BMT.
The NIA aging breeding colonies were rederived from stocks
obtained from The Jackson Laboratory (Bar Harbor, ME) in
2005, and do not carry the Crb1rd8 mutation. The absence of
the mutation was confirmed by PCR. Similarly, ‘‘donor’’ BM-
derived whole or purified CD34þ cells were isolated from
young and old female C57BL/6J transgenic mice expressing
green fluorescent protein (GFP; The Jackson Laboratory).
Murine Bone Marrow Transplantation
Bone marrow transplantation was performed as described
previously.10 Briefly, BM was extracted from either wild-type
or GFP young and old donor mice (n ¼ 10 per cohort) by
flushing RPMI-1640 medium in the diaphyseal channel of
both tibias and femurs. Basement membrane was homoge-
nized and filtered; and isolated unpurified BM cells, devoid of
red blood cells, were transplanted into the retro-orbital sinus
of lethally irradiated (950 cGy) young or old recipient mice (n
¼ 8 for each group). Blood components were allowed to
reconstitute for 1 month before induction of experimental
CNV. Chimerism was routinely greater than 90%. In a
preliminary study, the heads of mice were shielded by a lead
chamber during irradiation.
Enrichment of Lineage-Negative Cells From
Murine Bone Marrow
Whole BM cells were depleted of mature lineage-positive
hematopoietic cells and enriched of precursor cells (Lineage
Cell Depletion Kit; Miltenyi Biotec, Auburn, CA). Briefly, BM
cells obtained from young (n¼10) or old (n¼10) donor mice
were filtered through a 40-lm cell strainer (BD Falcon,
Franklin Lakes, NJ). A single-cell suspension of 107 cells was
labeled with 20 lL anti-Biotin microBeads (Miltenyi Biotec)
and subjected to magnetic column separation using the
autoMACS separator (Miltenyi Biotec, Auburn, CA). The
enriched unlabeled lineage-negative cell fraction was eluted
and collected for further manipulation.
Adoptive Transfer of CD34þ Cells and Splenic
Macrophages
CD34þ cells were enriched by incubating 107 whole BM cells,
isolated as detailed above (n¼ 20 young or old GFP mice) and
devoid of red blood cells, with rat anti-mouse CD34þ
conjugated with phycoerythrin (PE; BD Biosciences, Pharmin-
gen, San Diego, CA) for 30 minutes at 48C. Cells were then
labeled with 20 lL MACS anti-PE microBeads (Miltenyi Biotec)
and subjected to magnetic column separation for positive
isolation. CD34þ cells were 49% of total collected as
determined by flow cytometry. For splenic macrophage
isolation, spleens were harvested aseptically (n ¼ 20 young
or old GFP mice), cut into small pieces, mashed with a spatula,
and filtered to single-cell suspension. Splenocytes were
subjected to a similar enrichment protocol, described above,
using rat anti-mouse F4/80þ conjugated to PE (Abcam, Cam-
bridge, MA). In both cases, cells were counted, and 105 CD34þ
or F4/80þ cells were given intravenously to each recipient
mouse (n ¼ 8 per group) immediately after the CNV laser
procedure.
Western Blot Analysis
Whole cell protein extracts (M-PER; Pierce Thermo Scientific,
Rockford, IL) of unpurified BM or lineage-negative precursor
cells were denatured in NuPAGE LDS sample buffer (Invitrogen
Life Technologies, Grand Island, NY) under reducing condi-
tions, separated on 4% to 12% gradient Bis-Tris gels, and
transferred to nitrocellulose membranes. Primary antibodies
and dilutions used were smooth muscle 22 (SM22, 1:1000;
Abcam), von Willebrand factor (vWF, 1:200; Santa Cruz
Biotechnologies, Santa Cruz, CA), and CD31 (1:200; Abcam).
Secondary antibodies used were horseradish-peroxidase–con-
jugated donkey anti-mouse and donkey anti-rabbit (1:10,000
and 1:5000, respectively; Jackson ImmunoResearch, West
Grove, PA). Immunoreactive bands were visualized by chemi-
luminescence (ECL Plus; GE HealthCare, Piscataway, NJ). All
lanes were loaded with 15 lg cell lysate. Relative differences
between SM22 and CD31 or vWF expression for each
condition were expressed as the ratio of densitometry between
the two markers for each lane.
Laser-Induced CNV Model, Fluorescein
Angiography, and Choroidal Flat Mount
Morphometric Analysis
One month after BMT or immediately after adoptive transfer,
experimental CNV was induced according to published
procedures.4 At 4 weeks postlaser, all analyses were per-
formed. Fluorescein angiography (FA) was performed in a
subset of animals using a modified approach to a previously
described technique.4 Briefly, sodium fluorescein 10% (0.1 mL
100 mg/mL; Akorn, Decatur, IL) was injected intraperitoneally
into anesthetized mice. The angiograms were recorded using a
Spectralis scanning laser ophthalmoscope camera (Heidelberg
Engineering, Vista, CA) using the FA setting. Photographs were
obtained at approximately 1 and 4 minutes after dye injection.
In some mice, in vivo perfusion with fluorescein isothiocya-
nate (FITC)-dextran was used to determine vascular area
(Sigma-Aldrich, St. Louis, MO). All mice were then perfused
intracardially with 4% paraformaldehyde (PFA) for 10 minutes
and euthanized; eyes were removed for histopathological
analysis (left eye) and choroidal flat mount analysis (right
eye). The vascular surface area of CNV lesions in flat mounts
was determined by evaluating the FITC-dextran–positive area.
Cell density analysis of flat mounts was performed using
propidium iodide (PI; Sigma-Aldrich) fluorescence as previous-
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FIGURE 1. Quantitative analysis of cellular density in experimental CNV lesions developed in mice after BMT. Flat mounts were prepared from the
posterior pole of recipient mice eyes and stained with propidium iodide. Small lesions developed in young unmanipulated mice (A) and also when
young BM was transplanted into either young ([B], Y-to-Y) or old mice ([C], Y-to-O). In contrast, old unmanipulated mice (D) and the old-to-old group
(E) developed large neovascular lesions with connections between adjacent lesions. Additionally, young recipients receiving old BM ([F], O-to-Y)
developed intermediate-size lesions, often with adjacent lesions becoming interconnected. (G) Quantitative analysis of the surface area of CNV lesions
in each group. Significant differences were observed (asterisks) when old BM was transplanted in both young and old recipients in comparison with
transplantation of young BM (t-test: P < 0.001). D, optic disc. White line encircles CNV lesions. Magnification: 350; scale bar: 200 lm.
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ly described.4 Vascular morphology visualization was per-
formed by incubating flat mounts overnight in either
biotinylated lectin (BS-1, 1:1000; Sigma-Aldrich) or TRITC-
lectin (1:100; Sigma-Aldrich). For area calculations, the lesion
area in pixels was normalized by dividing the lesion area by the
mean value of optic disc area (mean value of 10 independent
eyes). A CNV was defined as present if the surface area of an
individual lesion was more than 0.50 disc areas (the diameter
of the laser burn).4 The results are presented as relative disc
areas.
Histology and Immunohistochemistry
Eyes were postfixed for 1 hour in 4% PFA, cryoprotected,
optimal cutting temperature (OCT) embedded, and snap
frozen in liquid nitrogen. Serial sections (14 um) were either
stained with hematoxylin-eosin for morphological evaluation
or incubated overnight with the following antibodies: anti-GFP-
Alexa 488 (1:1000; Molecular Probes—Life Technologies,
Grand Island, NY), anti-F4/80 (1:500; AbD Serotec, Raleigh,
NC), anti-alpha smooth muscle actin (SMA) conjugated to Cy3
(1:20,000; Sigma-Aldrich), anti-CD31 (PECAM-1, 1:500; Santa
Cruz Biotechnology), or anti-collagen IV (1:400; Abcam).
Immunostaining other than for GFP and SMA was visualized
using Alexa 568-conjugated secondary antibodies (1:500;
Molecular Probes—Life Technologies). Cell nuclei were stained
with 40,60-diamino-2-phenylindole (DAPI; Molecular Probes—
Life Technologies). Slides were mounted with aqueous
mounting medium (Crystal Mount; Biomeda, Foster City, CA)
and coverslipped.
Data Analysis
Serial cross sections of eyes containing CNV lesions were
examined for the presence of GFP-labeled cells and expression
of different cell markers using a fluorescent microscope
(Axiophot Photomicroscope; Carl Zeiss Microscopy, Thorn-
wood, NY) and a four-channel laser scanning confocal
microscope (LSM 510; Carl Zeiss Microscopy). Images were
digitally acquired (Axiovision or LSM Image Browser version
3.2; Carl Zeiss Microscopy) and recompiled (Photoshop 6.0;
Adobe, San Jose, CA). For confocal imaging, thin optical
sections (1 lm) were examined to ensure that overlapping
fluorescence was due to colocalization. Images shown are
representative. The percentage of macrophages or endothelial
or perivascular cells per lesion was calculated as the number of
positive cells divided by DAPI-positive cells 3 100. Cell
numbers for each eye were calculated as the average from at
least three sections from separate CNV lesions per eye.
Morphometric data resulting from flat mount and histological
samples for different lesions in each eye were averaged (n¼ 8)
to provide one value per eye. Data are presented as the mean
6 SEM. Statistical tests (t-test, ANOVA) were used to compare
treatments and groups using Prism 4.0 (GraphPad Software, La
Jolla, CA).
RESULTS
Characteristics of CNV Lesions After BMT From
Young or Old Donors
We have previously shown that CNV lesions that develop in
aged mice are approximately 2- to 3-fold larger than in young
mice, manifesting larger-caliber vessels and more fibrosis.4 In
the present study, we sought to evaluate age-dependent
regulation of CNV severity by BM resident cells by performing
BMT. Six total groups were assessed. Two groups were normal
controls, representing young and old mice, which did not
receive irradiation and BMT. The other four groups consisted of
8 recipient and 10 donor wild-type mice each. Two groups
represented controls of young and old recipient mice receiving
whole BM from age-matched animals (young-to-young [Y-to-Y]
and old-to-old [O-to-O]). Two experimental groups consisted of
mice engrafted with whole BM isolated from old donors into
young animals (old-to-young [O-to-Y]) and vice versa (young-to-
old [Y-to-O]).
We used choroidal flat mount analysis of cellular density to
determine CNV size. As shown previously, normal young mice
(Fig. 1A) demonstrated small lesions while normal aged mice
developed large lesions (Fig. 1D). The group of young mice
receiving BMT from young donors (Y-to-Y) developed small
CNV lesions (Fig. 1B, 1.49 6 0.29 disc areas [DA]), similar in
size to those observed in unmanipulated young mice. Further,
old mice receiving BMT from old donors (O-to-O) developed
large CNV lesions (Fig. 1E, 3.42 6 1.1 DA), comparable to
those in unmanipulated old mice. Thus, irradiation and BMT
process did not specifically alter the lesion size from the
expected outcomes in unmanipulated mice. In contrast, when
aged mice received BM from young mice, they developed small
lesions similar to those in young mice (Fig. 1C, 1.9 6 0.1 DA).
Conversely, young mice that received aged (O-to-Y) BMT
developed intermediate-size lesions (Fig. 1F, 2.60 6 0.69 DA).
Comparative analysis of differences in CNV area of the six
groups is shown in Figure 1G. Statistically significant differ-
ences were observed between mice receiving BMT of Y-to-Y
versus O-to-Y and Y-to-O versus O-to-O. However, mice
receiving O-to-O versus O-to-Y and Y-to-Y versus Y-to-O were
not different. In summary, BMT transferred susceptibility to
disease severity in laser-induced CNV according to the age of
the BM donor. That is, old BM transferred susceptibility to the
development of intermediate-to-large lesions into young mice,
and young BM prevented old recipient mice from developing
large lesions.
We evaluated the vascularity pattern of laser CNV among
different groups using FA and analysis of CNV vascular lesion
flat mounts. Representative FA images taken at early (~1
minute, Figs. 2A, 2D, 2G) and late (~4 minutes, Figs. 2B, 2E,
2H) time points demonstrate relative lesion sizes and
associated leakage activity across groups. Young mice demon-
strated small well-circumscribed lesions with minimal late
leakage (Figs. 2A, 2B), while old mice demonstrated large,
often confluent lesions, with active late leakage (Figs. 2D, 2E).
Lesions in young mice receiving old marrow (O-to-Y)
demonstrated intermediate-size lesions, but also with active
late leakage (Figs. 2G, 2H).
TRITC-lectin–labeled flat mount images representing spe-
cific lesions on the FA demonstrated distinct differences in
vascular morphology. Young mice demonstrated small lesions
with small-caliber vascular networks (presumed capillaries),
minimal discernible arterioles, and well-demarcated margins
(Fig. 2C). In contrast, old mice (Fig. 2F) demonstrated large
lesions composed of some small capillaries, many large-
diameter branching arterioles (Fig. 2F, arrow), and extensions
of large-diameter vascular loops at the lesion margins (Fig. 2F,
arrowhead). O-to-Y mice had intermediate-size lesions (Fig. 2I)
but with vascular morphology similar to that of lesions in old
mice: some capillaries and marginal vascular loops (arrow-
head) and many large-caliber branching arterioles (arrows).
The presence of large-caliber arterioles and marginal vascular
loops is consistent with NVR.
Finally, measurement of vascular surface area across
transplant groups by FITC-dextran perfusion was consistent
with the FA and cellular flat mount results for lesion size. Bone
marrow transplantation of Y-to-Y resulted in small vascular
area; BMT of O-to-O resulted in large vascular area; and BMT of
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O-to-Y transferred intermediate-sized vascular lesions into the
young recipients. These were significantly larger than lesions
in the Y-to-Y group (Fig. 3).
We used histopathology to compare cross-sectional mor-
phology of experimental CNV after BMT. Sections from the Y-to-
Y group revealed small lesions (Fig. 4A), which were
comparable to those previously observed in unmanipulated
young mice.4 In contrast, sections from the O-to-Y group
revealed large, thick CNV lesions (Fig. 4B). Comparison of the
mean cross-sectional area between the Y-to-Y and the O-to-Y
group showed a 62% size increase (Fig. 4C, 70.6 6 11.7 vs.
114.7 6 20.6 3 1000 pixels2). In a pilot experiment, the head
of recipient mice was shielded from irradiation without
apparent change in the morphology or outcome (data not
shown). Thus, no evidence of radiation retinopathy or other
potential changes from the irradiation required for BMT were
apparent.
Aged BMT was found to increase the frequency of large
lesions. Using 1.9 disc area cutoff (representing the 95%
confidence interval for lesion size in unmanipulated young
mice), only 14% of the total number of lesions in Y-to-Y
FIGURE 3. Quantitative analysis of vascular surface area in experimen-
tal CNV lesions after BMT. Quantitative analysis of the vascular surface
area of CNV lesions (FITC-dextran perfusion) of each group showed
significant differences (asterisks) between the young-to-young com-
pared to the old-to-young and the old-to-old groups (t-test: P < 0.003)
and among all three groups (ANOVA: P < 0.0017). The differences
between old-to-young and old-to-old were not statistically significant.
FIGURE 2. Vascular morphology in experimental CNV lesions by fluorescein angiography and lectin-stained flat mount. Early (~1 minute) and late
(~4 minutes) FA photographs were obtained to characterize lesion size and leakage activity of experimental CNV. Lectin-stained vascular flat mounts
were obtained to characterize differences in vascular morphology (magnification: 3100; scale bars: 100 lm). Young mice demonstrated small
lesions, well-demarcated borders, and mild fluorescein leakage (A, B). Lectin-stained flat mount analysis of one of these lesions (corresponding to
red box [B]) demonstrated well-defined, small-diameter capillary networks with minimal discernible large-caliber arterioles (C). FA from old mice
demonstrated large, confluent CNV with very active fluorescein leakage (D, E). Lectin-stained flat mount from one of these CNV lesions
(corresponding to red box [E]) revealed many large branching arterioles (arrow) and vascular loops at the lesion margins (arrowhead) (F). Lesions
from young mice transplanted with old marrow (O-to-Y) demonstrated intermediate size but very active fluorescein leakage (G, H). Lectin-stained
flat mount from one lesion (corresponding to red box [H]) revealed morphology similar to that of lesions in old eyes, including some capillaries and
marginal vascular loops (arrowhead), and many large-caliber branching arterioles (arrows) (I).
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exceeded this size. In contrast, the frequency of intermediate-
to-large lesions in O-to-O was 85%. In young mice receiving old
BM, the frequency of intermediate-to-large lesions was 69%.
Taken together, these results indicate that the age of the BM,
and not the age of the choroid, Bruch’s membrane, and outer
retina, is the primary determinant of CNV severity. This finding
suggests that cellular components present in aged BM regulate
the degree of fibrosis, size, and vascular maturation.
Contribution of Different Cell Subtypes to CNV
Lesions in Mice Receiving Young or Old BM
To characterize the identity of cells within each lesion,
experimental-laser CNV lesions from young recipients receiv-
ing either young or old BM were analyzed with specific cell
markers for macrophages (F4/80), endothelial cells (CD31), or
perivascular mesenchymal cells (SMA). The proportion of F4/
80þ blood-derived macrophages was identical in the two
groups (23% in Y-to-Y and 24% in O-to-Y, data not shown). Also,
in spite of the substantial difference in lesion size, the
proportion of endothelial cells present was not significantly
different between young mice receiving young or old marrow
(Fig. 5A, 36.3 6 0.04% vs. 40.5 6 0.05%, respectively).
We previously demonstrated that CNV lesions in non-
transplanted old mice were not only larger but also more
fibrotic and demonstrated more SMAþ cells, presumably
representing perivascular mesenchymal precursor-derived cell
types such as pericytes, vascular smooth muscle cells, or
myofibroblasts.4 Similar findings were observed in the O-to-Y
group, in which the frequency of SMA-expressing cells was
significantly greater than in the Y-to-Y group (34.2 6 0.04% O-
to-Y versus 18.7 6 0.01% Y-to-Y, Fig. 5B). Conversely, the
degree of fibrosis and proportion of SMAþ cells in the Y-to-O
group was not statistically different from values in the Y-to-Y
group (Fig. 5C), indicating that young marrow conveys the
young perivascular mesenchymal phenotype into old recipi-
ents.
Immunohistochemistry was performed to detect collagen
type IV levels in order to demonstrate qualitative changes in
extracellular matrix deposition, another well-known sign of
fibrosis. As expected, small lesions from unmanipulated young
mice (Fig. 6A) showed less collagen IV immunoreactivity than
large lesions in aged mice (Fig. 6B). Old mice receiving BMT
from young donors demonstrated collagen deposition similar
to that in the unmanipulated young mice (Fig. 6C).
Contribution of Resident Versus Recruited Bone
Marrow Cell Subtypes to CNV Lesions After BMT
In BMT experiments using young GFP donor cells, we have
observed that up to 40% of the endothelial and perivascular
mesenchymal cell types within CNV lesions are BM de-
rived.10,20 Using young or old GFP-labeled BM, we differenti-
ated between the relative proportion of resident-derived and
recruited donor-derived endothelial and perivascular mesen-
chymal cell subsets. No difference was observed between
young mice engrafted with young or old BM in terms of
proportion of total CD31, resident-derived (GFP/CD31þ), or
recruited marrow-derived (GFPþ/CD31þ) endothelial cells (Fig.
7C, top). In terms of SMAþ perivascular mesenchymal cells,
both groups of mice (Y-to-Y and O-to-Y) demonstrated high
frequency of resident SMA-expressing cells (red, arrowheads)
and GFP-labeled BM-derived cells; many more double-positive
cells (yellow, arrows), representing BM-derived SMA/GFP-
expressing cells, were observed in cross sections from mice
receiving old marrow (Figs. 7A, 7B). Quantitative assessment
(Fig. 7C, bottom) revealed that the proportion of total SMAþ
population was significantly greater in O-to-Y than in Y-to-Y,
similar to data in Figure 5. Although the specific resident-
derived subset of SMAþ perivascular mesenchymal cells was
greater in O-to-Y than in Y-to-Y, the differences in proportion
were less than observed for the total SMAþ group. However,
recruited, marrow-derived SMAþ cells demonstrated a greater
increase (almost 2.5-fold) in O-to-Y than in Y-to-Y. We conclude
that the greatest difference in cellular subsets was the
significantly increased proportion of BM-derived SMAþ peri-
vascular mesenchymal cells in mice with severe CNV after
receiving aged BMT. No subset of endothelial cells showed any
proportional increase in mice receiving old BM with severe
CNV.
Engraftment of CD34þ and F4/80þ Cells Following
Adoptive Transfer
We have previously shown that macrophage infiltration
contributes to increased CNV severity.21 To further differenti-
ate the relative contribution of BM vascular cells from
macrophages, and to rule out possible artifacts induced by
the total body irradiation required prior to BMT, adoptive
FIGURE 4. Histopathology sections of experimental CNV after young
or old BMT into young recipient mice. Sections were stained with
hematoxylin and eosin. CNV lesions were significantly less severe in
young mice that received young BM ([A], Y-to-Y) when compared with
young mice transplanted with old BM ([B], O-to-Y). White arrowheads
show the margins of the CNV membranes. (C) A significant difference
in lesion size was observed between the two transplanted groups when
the mean cross-sectional area was quantitatively analyzed. Magnifica-
tion: 3100; scale bar: 100 lm.
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transfer experiments were performed. Although no definitive
marker specifically identifies the BM perivascular mesenchymal
precursor population, they are thought to express CD34 (also
expressed on some monocyte precursors, endothelial precur-
sors, and other cell types).22 Unmanipulated mice received
intravenous infusion of CD34þ cells purified from BM or F4/80
splenic macrophages, purified from young or old GFPþ mice.
Laser treatment to induce experimental CNV was done on the
same day as cellular infusion or 1 week prior to infusion.
As shown in Figures 8A and 8B, young mice receiving
CD34þ cells from old marrow developed significantly larger
lesions than those receiving young CD34þ cells (Fig. 8C, 2.8 6
0.4 vs. 1.5 6 0.1 DA, t-test: P < 0.0115). Immunohistochem-
istry of CNV lesions from mice receiving old CD34þ cells
showed incorporation of CD34þ/GFPþ marrow cells into the
lesions (Fig. 8D). Interestingly, no significant difference in
lesion size was observed in young mice receiving either young
or old F4/80þ macrophages (Fig. 8E). The timing of the
adoptive transfer during the course of CNV development was
important in terms of transferring the more severe phenotype.
When cells were transferred 7 days after CNV induction rather
than on the same day, adoptive transfer of CD34þ cells from
old marrow did not produce the expected increase in severity
(Fig. 8E). These results suggest that cells resident within the
FIGURE 5. Immunofluorescence detection of endothelial and perivascular mesenchymal cells present in CNV lesions after BMT. Endothelial cells
were stained with CD31 (left) and perivascular mesenchymal cells with SMA (center and right). In spite of the difference in lesion size, the
frequency of endothelial cells (A) was not significantly different between the young-to-young (36.3 6 0.04%) and the old-to-young group (40.5 6
0.05%). In contrast, a significant increase (asterisk) in the frequency of SMA-expressing cells (B) was observed when the old-to-young group (34.2 6
0.04%) was compared to the young-to-young group (18.7 6 0.01%, t-test: P < 0.002). (C) No significant increase in the frequency of SMA-expressing
cells (arrowheads) was observed between the young-to-young (18.22 6 0.01%) and the young-to-old group (20.7 6 0.02%, t-test: P ¼ 0.360).
Magnification: 3400; scale bars: 100 lm; CD31 (left) or SMA (center and right), red; DAPI, blue.
FIGURE 6. Levels of collagen type IV deposition present in CNV lesions. Cryosections with representative CNV lesions were stained with an
antibody to collagen type IV to determine extent of fibrosis in the different groups. The amount of collagen IV deposition was greater in CNV lesions
of old (B) compared to those of young (A) unmanipulated mice. In contrast, a decrease in collagen deposition was observed in CNV lesions in
young-to-old mice (C) when compared to old unmanipulated mice. White lines outline neovascular lesions. Magnification: 3200; scale bar: 100 lm.
Collagen type IV (red), DAPI (blue).
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CD34þ cell subset of the BM are crucial in the development of
NVR. Importantly, the causative cells must be present early
during lesion development in order to transfer the more severe
phenotype. Finally, these findings support the conclusion that
irradiation-induced artifact did not account for the observed
increased severity after BMT.
Expression Levels of Perivascular and Endothelial
Markers in BM From Young and Old Mice
One possible explanation for the previous results is that old BM
contains a greater number or proportion of mesenchymal-
derived perivascular precursor cells. We sought to determine if
BM from old and young mice contained different relative
proportions of endothelial precursors and perivascular mesen-
chymal precursors. We evaluated the relative expression of
endothelial and perivascular mesenchymal markers in whole
BM, freshly isolated lineage–negative cells, and CD34þ isolated
cells (Fig. 9A). Western blot analysis revealed a higher
expression of the mesenchymal marker SM22 in old compared
to young whole BM. In contrast, BM cells isolated from young
and aged mice showed similar expression of the endothelial-
specific marker vWF.
Whole marrow contains ‘‘mature’’ nonprecursor mesenchy-
mal populations that also express SM22 (i.e., fibroblasts). To
confirm that an authentic population of mesenchymal-derived
perivascular precursor cells, and not merely contaminating
fibroblasts, was present in the marrow, we evaluated SM22
expression in subpopulations enriched for precursors but
excluding fibroblasts. As shown in Figure 9B, enriched CD34þ
cells also expressed SM22, excluding fibroblast contamination.
However, CD34þ cells isolated from old marrow demonstrated
higher relative expression of SM22 as compared to young
CD34þ cells. In contrast, comparable expression of the
endothelial-specific marker CD31 was observed between
young and old. These results suggest that the ratio of
perivascular mesenchymal precursor cells to endothelial
precursor cells increases with age, or conversely, the number
of endothelial precursor cells decreases with age (Fig. 9B).
Taken together with data from Figures 7 and 8, this observation
adds support for the hypothesis that BM-derived perivascular
derivatives within CNV may originate from the CD34þ subset
within the BM, and that increased number or proportion of
CD34þ mesenchymal-derived perivascular precursor cells in
older mice might be important in the development of NVR.
DISCUSSION
Two main conclusions about laser-induced CNV can be drawn
from these data. First, this study confirms our prior work
showing that aging is associated with NVR, defined as increase
in size, leakage activity, arteriolar-predominant vascular mor-
phology, perivascular fibrosis, and proportion of SMAþ
perivascular mesenchymal cells relative to endothelial cells
when compared to values in young mice with small, capillary-
like lesions.4,10,11 Second, susceptibility to NVR is conveyed by
the chronologic age of cells within the BM, and not by the
chronologic age of the retina or choroid.
These data also suggest that perivascular mesenchymal
precursor cells with the aged marrow are important for the
development of NVR in CNV and specifically raise the
possibility that circulating perivascular mesenchymal precur-
sor cells may contribute to NVR directly by differentiating into
vascular smooth muscle cells and/or myofibroblasts,23 a
previously undescribed phenomenon that will require further
study. Choroidal neovascularization with NVR demonstrated
almost 2.5-fold more marrow-derived perivascular mesenchy-
mal SMAþ cells than in small, capillary CNV. However, we
cannot exclude endothelial to myofibroblast transition.24
How does aged bone marrow regulate NVR? One possibility
may be due to an increased frequency of marrow precursors
with age. However, since BM contains macrophages as well as
perivascular mesenchymal precursors, we cannot exclude the
impact of age on monocytes. In fact, it is likely that both
FIGURE 7. Immunofluorescence detection of resident or recruited BM-
derived SMA-expressing perivascular mesenchymal cells in CNV lesions
after BMT. Young mice received young (A) or old (B) GFP BM, followed
by laser-induced CNV. Although both groups demonstrated high
frequency of resident SMA-expressing cells (red, arrowheads) and
GFP-labeled BM-derived cells, many more double-positive cells (yellow,
arrows), representing BM-derived SMA/GFP-expressing cells, were
observed in cross sections from mice receiving old marrow.
Quantification of the frequency of total, resident, and BM-derived
CD31 endothelial cells ([C], top) showed no difference in resident or
BM-derived CD31-expressing endothelial cells between mice receiving
young or old marrow. In contrast, significant differences (asterisks)
were observed in the frequency of both resident and BM-derived SMA-
expressing cells in CNV of mice receiving marrow from young versus
old donors ([C], bottom). In particular, mice receiving old marrow had
a 2.5-fold increase in marrow-derived SMA-expressing perivascular
mesenchymal cells, contributing to nearly half of all SMA-expressing
cells in the CNV. SMA, red; GFP, green; colocalization of GFP and SMA,
yellow; DAPI, blue. Magnification: 3400; scale bars: 20 lm.
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macrophages and perivascular mesenchymal precursors are
necessary for NVR. Apte and others have demonstrated the
important role of aged macrophages in regulating CNV
severity.25 Circulating BM-derived perivascular mesenchymal
precursor cells might be recruited into the lesion by factors
including stromal cell-derived factor-1 (SDF-1),26 platelet-
derived growth factor-AB (PDGF-AB), insulin-like growth factor
1 (IGF-1),27 and osteopontin.28 A reasonable hypothesis is that
macrophages may be a major source of the factors promoting
the chemotaxis and differentiation of perivascular mesenchy-
mal precursor cells.
Adoptive transfer experiments of CD34þ cells in young
mouse recipients in concert with SM22 expression data in
whole BM and CD34þ cells suggest that old CD34þ perivas-
cular precursors transfer age-related pathology by directly
incorporating into the CNV lesion. Although adoptive transfer
did not precisely mimic the biology of whole BM transplanta-
tion, our results argue against radiation-induced artifacts as an
important mechanism in our observation.29 In addition, the
ability of adoptive transfer to recreate the lesion severity
suggests that the contribution of precursors to the severe
phenotype probably occurs early in the neovascular process.
This result is evident not only from our current findings (i.e.,
old CD34þ cells transferred late in the induction process of
CNV lesions) but also since the adoptively transferred cells are
likely to be cleared from the circulation within a few days after
administration.29
Another potential difficulty in interpreting our results is that
the laser-CNV model used in this study may not completely
recapitulate all the feature of human CNV lesions. Neverthe-
less, the morphology of human CNV is highly variable, and
many examples do demonstrate extensive fibrosis and branch-
ing new vessels similar to this model.30 Also, we have
previously shown that vascular precursors contribute signifi-
cantly in a model of CNV driven by VEGF overexpression.20
Thus, we believe that our results can be extrapolated to human
CNV in AMD in which the pathophysiology is more complex.
Another complexity in interpretation of our results is the
variability in lesion size in O-to-Y mice as well as in old mice
without radiation or BMT. Generally, within an experiment,
there is less variability in lesion size in young mice with small
lesions. Some of the variability in other groups is statistical
(large lesions have greater potential ranges in size, creating
more variation) as well as biological (unknown variations in
environmental insults and exposures over a mouse lifetime that
regulate the severe aging phenotype in the marrow). The
observation that lesion size in O-to-Y mice was intermediate
between young and old unmanipulated mice might also
suggest that there are factors in addition to the BM that
regulate lesion size. However, with all the data taken together,
we believe that the consistent differences between young mice
and O-to-Y mice observed across multiple CNV parameters
(size, leakage, vascular morphology, perivascular fibrosis, and
cellular composition) were not only statistically significant but
also physiologically meaningful.
The clinical relevance of these findings is that circulating
perivascular mesenchymal precursor cells may play a role in
regulating the severity of human CNV. The concept that NVR
FIGURE 8. Analysis of CNV lesions in young animals receiving adoptive transfer of CD34þ-GFP-labeled cells. CD34þ precursor cells obtained from
young or old donors were adoptively transferred to young recipient mice at the time of laser-induced CNV (without prior irradiation or BMT). Flat
mounts were prepared and stained with PI. (A) Mice receiving adoptive transfer of CD34þ cells isolated from a young donor display typical small
CNVs. (B) In contrast, animals receiving adoptive transfer of CD34þ cells from old donors developed large CNVs. D, optic disc; white lines encircle
CNV lesions. Magnification: 350; scale bar: 200 lm. (C) Quantitative analysis of surface area showed a significant size increase (asterisk) in animals
engrafted with CD34þ cells from old donors as compared with young donors. (D) Immunohistochemistry of mouse eye cross sections with CNV
lesion showed recruitment and engraftment of adoptively transferred GFPþ cells (arrows) within 3 days after CNV induction. GFP, green; DAPI,
blue. Magnification: 3400; scale bar: 20 lm. (E) Quantitative analysis of cellular density after adoptive transfer of young or old CD34þ cells versus
young or old macrophages (F4/80). Mice receiving old CD34þ cells developed CNV lesions that are approximately double in size (asterisk) when
compared to those in the other groups. Adoptive transfer of young or old F4/80þ splenic macrophages failed to induce any increase in severity,
similarly to adoptive transfer of CD34þ cells from old marrow transferred 7 days after CNV induction.
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contributes to human neovascular AMD and has therapeutic
implications is relatively new (Mettu PS, et al. IOVS
2012;53:ARVO E-Abstract 2654). Postmortem and surgically
excised histopathological specimens of human CNV demon-
strate that they are not simple endothelial lined tubes, but are
morphologically complex fibrovascular lesions containing
many different cells types with significant extracellular matrix
and fibrosis.30 In vivo imaging technologies reveal a diverse
pattern of vascular maturation in human CNV ranging from
capillary subtypes to arteriolarized vascular complexes with
minimal capillary structure. Large lesions in patients tend to be
more arteriolarized and fibrotic.31 Recent clinical trial data
documented that 50% to 80% of eyes with neovascular AMD
demonstrate residual vascular leakage in spite of a year of anti-
VEGF therapy,32 indicating that neovascular AMD lesions
demonstrate differential sensitivity to anti-VEGF therapy. We
hypothesize that many of these resistant cases are caused by
CNV with neovascular remodeling.
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